Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1980 Sep;12(3):421–423. doi: 10.1128/jcm.12.3.421-423.1980

Protease production by clinical isolates of type III group B streptococci.

D C Straus, S J Mattingly, T W Milligan, T I Doran, T J Nealon
PMCID: PMC273600  PMID: 7012176

Abstract

Six strains of serotype III group B streptococci isolated from confirmed cases of neonatal disease were examined for their ability to produce proteolytic enzymes. Three neuraminidase-producing strains and three non-neuraminidase-producing strains were employed in this study. Protease production was examined in 1,000-fold concentrated filtrates of stationary-phase cells with an insoluble substrate derived from horse hide powder labeled covalently with Remazol brilliant blue. Protease activity was not detected in any cultural supernatant fluids until they were fractionated on Sephadex G-100. After fractionation, the neuraminidase-producing strains were shown to elaborate approximately sixfold more protease than the non-neuraminidase-producing strains. The finding that clinical isolates of group B streptococci that elaborated high levels of neuraminidase also produced elevated levels of extracellular protease may indicate that the production of several different factors may determine the virulence of these organisms.

Full text

PDF
421

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernheimer A. W., Linder R., Avigad L. S. Nature and mechanism of action of the CAMP protein of group B streptococci. Infect Immun. 1979 Mar;23(3):838–844. doi: 10.1128/iai.23.3.838-844.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown J., Farnsworth R., Wannamaker L. W., Johnson D. W. CAMP factor of group B streptococci: production, assay, and neutralization by sera from immunized rabbits and experimentally infected cows. Infect Immun. 1974 Feb;9(2):377–383. doi: 10.1128/iai.9.2.377-383.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cowman R. A., Perrella M. M., Fitzgerald R. J. Caseinolytic and glyoprotein hydrolase activity of Streptococcus mutans. J Dent Res. 1976 May-Jun;55(3):391–399. doi: 10.1177/00220345760550031701. [DOI] [PubMed] [Google Scholar]
  4. DEIBEL R. H. HYDROLYSIS OF PROTEINS AND NUCLEIC ACIDS BY LANCEFIELD GROUP A AND OTHER STREPTOCOCCI. J Bacteriol. 1963 Dec;86:1270–1274. doi: 10.1128/jb.86.6.1270-1274.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elliott S. D. A PROTEOLYTIC ENZYME PRODUCED BY GROUP A STREPTOCOCCI WITH SPECIAL REFERENCE TO ITS EFFECT ON THE TYPE-SPECIFIC M ANTIGEN. J Exp Med. 1945 Jun 1;81(6):573–592. doi: 10.1084/jem.81.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferrieri P., Gray E. D., Wannamaker L. W. Biochemical and immunological characterization of the extracellular nucleases of group B streptococci. J Exp Med. 1980 Jan 1;151(1):56–68. doi: 10.1084/jem.151.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gutschik E., Møller S., Christensen N. Experimental endocarditis in rabbits. 3. Significance of the proteolytic capacity of the infecting strains of Streptococcus faecalis. Acta Pathol Microbiol Scand B. 1979 Dec;87(6):353–362. [PubMed] [Google Scholar]
  8. Hayano S., Tanaka A., Okuyama Y. Distribution and serological specificity of sialidase produced by various groups of streptococci. J Bacteriol. 1969 Oct;100(1):354–357. doi: 10.1128/jb.100.1.354-357.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayano S., Tanaka A. Sialidase-like enzymes produced by group A, B, C, G, and L streptococci and by Streptococcus sanguis. J Bacteriol. 1969 Mar;97(3):1328–1333. doi: 10.1128/jb.97.3.1328-1333.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holder I. A., Haidaris C. G. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors. Can J Microbiol. 1979 May;25(5):593–599. doi: 10.1139/m79-085. [DOI] [PubMed] [Google Scholar]
  11. Kjems E., Perch B., Henrichsen J. Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin. J Clin Microbiol. 1980 Feb;11(2):111–113. doi: 10.1128/jcm.11.2.111-113.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Milligan T. W., Baker C. J., Straus D. C., Mattingly S. J. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun. 1978 Sep;21(3):738–746. doi: 10.1128/iai.21.3.738-746.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milligan T. W., Straus D. C., Mattingly S. J. Extracellular neuraminidase production by group B streptococci. Infect Immun. 1977 Oct;18(1):189–195. doi: 10.1128/iai.18.1.189-195.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Patterson M. J., El Batool Hafeez A. Group B streptococci in human disease. Bacteriol Rev. 1976 Sep;40(3):774–792. doi: 10.1128/br.40.3.774-792.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pavlovskis O. R., Wretlind B. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infect Immun. 1979 Apr;24(1):181–187. doi: 10.1128/iai.24.1.181-187.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rinderknecht H., Geokas M. C., Silverman P., Haverback B. J. A new ultrasensitive method for the determination of proteolytic activity. Clin Chim Acta. 1968 Aug;21(2):197–203. doi: 10.1016/0009-8981(68)90127-7. [DOI] [PubMed] [Google Scholar]
  19. Straus D. C., Mattingly S. J., Milligan T. W. Effect on antibiotics on protease production by a viridans streptococcus. Antimicrob Agents Chemother. 1978 Oct;14(4):581–586. doi: 10.1128/aac.14.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Straus D. C., Mattingly S. J., Milligan T. W. Production of extracellular material by streptococci associated with subacute bacterial endocarditis. Infect Immun. 1977 Jul;17(1):148–156. doi: 10.1128/iai.17.1.148-156.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. TOENNIES G., GALLANT D. L. The relation between photometric turbidity and bacterial concentration. Growth. 1949 Mar;13(1):7–20. [PubMed] [Google Scholar]
  22. Terleckyj B., Willett N. P., Shockman G. D. Growth of several cariogenic strains of oral streptococci in a chemically defined medium. Infect Immun. 1975 Apr;11(4):649–655. doi: 10.1128/iai.11.4.649-655.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES